Physician profile
Cooper Rapp
NPI 1356876395
$480.94
in general payments reported to CMS, 2019-2025
12 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $163 · 2023: $59.29 · 2024: $151 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $112.14 | 2022 | |
| Novocure INC. | $78.81 | 2023-2025 | Optune, Optune Gio |
| Novartis Pharmaceuticals Corporation | $67.02 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $37.25 | 2022-2024 | Libtayo |
| Blue Earth Diagnostics | $34.73 | 2025 | Posluma |
| Boston Scientific Corporation | $32.90 | 2025 | Spaceoar Vue System - 10ml |
| Siemens Medical Solutions USA, INC. | $30.58 | 2024 | Edge |
| Lilly USA, LLC | $21.02 | 2024 | Verzenio, Retevmo, Jaypirca |
| Janssen Biotech, INC. | $20.00 | 2025 | Balversa, Erleada |
| Tersera Therapeutics LLC | $18.48 | 2022 | |
| Merck Sharp & Dohme LLC | $14.49 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.52 | 2024 | Iclusig |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cooper Rapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.